In the late thirty years biotechnology, with transgenic technology as its core，has been developed rapidly and applied in fields such as agriculture and medicine with great achievements， which has caused profound impacts on society and economy, However because of scientific uncertainties of influences of transgenrc technology and derived products on human, plant and animal life and health as well as the environment,biosafety。i.e management of biotechnology so as to minimize its potential risks to the environment and human health, has become an issue with increasing concern of the internatronal community，In this context, negotiation of an international treaty was initiated in 1996 and the Cartagena Protocol on Biosafety was adopted in January 2000 and came into effect in September 2003 ,As the first international treaty containing direct stipulations on living modified organisms (LMOs) trade, the Protocol encountered divergence and controversy in the negotiation process, After adoption of the Protocol, compatibility of its provisions with those set in the WTO agreements has turned into a hot issue for dispute in the international forum。
展开▼
